Fk 317

FK‑317 is a substituted dihydrobenzoxazine small-molecule antineoplastic agent that induces tumor-selective cytotoxic metabolites in cancer cells, achieving broad-spectrum antitumor efficacy in murine and human xenograft models while avoiding vascular leak syndrome . The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Fk 317 Dihydrobenzoxazine and FR 073317. Its PubChem CID is 121492536.

CAS No 102409-92-7
Molecular Formula C19H21N3O8
Molecular Weight 419.40 g/mol
Synonyms [(8R,10S,12S)-11-acetyl-8-(carbamoyloxymethyl)-4-formyl-6-methoxy-14-oxa-1,11-diazatetracyclo[7.4.1.02,7.010,12]tetradeca-2(7),3,5-trien-9-yl] acetate

Frequently Asked Questions